<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CINCA</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e> is an autoinflammatory disorder characterized by the triad of <z:hpo ids='HP_0003623'>neonatal onset</z:hpo> of cutaneous symptoms, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001287'>meningitis</z:hpo>, and recurrent <z:hpo ids='HP_0001945'>fever</z:hpo> and it presents with distinctive <z:e sem="disease" ids="C0263661" disease_type="Disease or Syndrome" abbrv="">osteoarthropathy</z:e>, <z:hpo ids='HP_0100769'>synovitis</z:hpo> mainly of the large joints and <z:hpo ids='HP_0001548'>overgrowth</z:hpo> of epimetaphyseal cartilage, particularly of the long bones </plain></SENT>
<SENT sid="1" pm="."><plain>The cartilage <z:hpo ids='HP_0001548'>overgrowth</z:hpo> eventually causes osseous <z:hpo ids='HP_0001548'>overgrowth</z:hpo> and deformity that persists beyond skeletal maturity and leads to limb length discrepancy, <z:hpo ids='HP_0001371'>joint contracture</z:hpo>, and early degenerative <z:hpo ids='HP_0003040'>arthropathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Autoinflammation in CAPS/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e> has been proven to derive from excessive release of interleukin-1 (IL-1) </plain></SENT>
<SENT sid="3" pm="."><plain>It has been well documented that the IL-1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> anakinra (Kineret(R)) helps mitigate systemic <z:mp ids='MP_0001845'>inflammation</z:mp> in the disorder </plain></SENT>
<SENT sid="4" pm="."><plain>However, a general consensus has not been reached on its beneficial effect on <z:e sem="disease" ids="C0263661" disease_type="Disease or Syndrome" abbrv="">osteoarthropathy</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The case of a girl with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CINCA</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e> syndrome who showed dramatic improvement of <z:e sem="disease" ids="C0263661" disease_type="Disease or Syndrome" abbrv="">osteoarthropathy</z:e> after anakinra treatment is reported </plain></SENT>
<SENT sid="6" pm="."><plain>A 4-year-old girl suffered at the age of 10 months from a generalized urticarial skin lesion with recurrent episodes of <z:hpo ids='HP_0001945'>fever</z:hpo> and growth disorder </plain></SENT>
<SENT sid="7" pm="."><plain>Blood examination revealed persistent massive <z:mp ids='MP_0000219'>neutrophilia</z:mp>, <z:hpo ids='HP_0001903'>anemia</z:hpo> and intense <z:hpo ids='HP_0011009'>acute</z:hpo> phase response </plain></SENT>
<SENT sid="8" pm="."><plain>She manifested knee <z:hpo ids='HP_0001386'>joint swelling</z:hpo> with limited ROM when she was 20 months old and was diagnosed as being <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CINCA</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOMID</z:e> based on characteristic findings of radiograph despite negative CIAS1 mutation </plain></SENT>
<SENT sid="9" pm="."><plain>Radiological examination demonstrated metaphyseal fraying and cupping and widening of the growth plate in the distal femur </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging showed mottled <z:chebi fb="0" ids="33375">gadolinium</z:chebi> enhancement at the chondrosseous junction </plain></SENT>
<SENT sid="11" pm="."><plain>Neither significant <z:e sem="disease" ids="C1253936" disease_type="Disease or Syndrome" abbrv="">joint effusion</z:e> nor <z:hpo ids='HP_0100769'>synovitis</z:hpo> was identified </plain></SENT>
<SENT sid="12" pm="."><plain>At 2 years and 7 months of age, anakinra, 2 mg/kg/day given by regular daily subcutaneous injections, was started </plain></SENT>
<SENT sid="13" pm="."><plain>A few days after the initiation of the treatment, her clinical symptoms and laboratory findings of active <z:mp ids='MP_0001845'>inflammation</z:mp> were promptly alleviated </plain></SENT>
<SENT sid="14" pm="."><plain>She was not able to walk unaided prior to the treatment, but she walked independently 1 month after the treatment </plain></SENT>
<SENT sid="15" pm="."><plain>Follow-up radiographs and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging showed that growth plate widening and <z:chebi fb="0" ids="33375">gadolinium</z:chebi> enhancement at the chondrosseous junction were less conspicuous </plain></SENT>
<SENT sid="16" pm="."><plain>Furthermore, longitudinal growth of the femur and tibia was identified during 20 months of observation </plain></SENT>
</text></document>